![]() | Only 14 pages are availabe for public view |
Abstract The aim of present study was to screen for -509 C/T SNP in the TGF-β1 promoter among some asthmatic patients and healthy subjects as control group to determine: 1. The prevalence of -509T C/T SNP in asthmatic patients and control group and its association with asthma susceptibility and severity. 2. Its effect on TGF-β1 plasma level in asthmatics in comparison with control group. 3. Its effect on serum total IgE level and peripheral blood eosinophil count (PBEC). |